Validation of the 2(nd) Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis

Proteasome inhibition has been shown to prevent development of fibrosis in several organs including the lung. However, effects of proteasome inhibitors on lung fibrosis are controversial and cytotoxic side effects of the overall inhibition of proteasomal protein degradation cannot be excluded. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Semren, Nora, Habel-Ungewitter, Nunja C., Fernandez, Isis E., Königshoff, Melanie, Eickelberg, Oliver, Stöger, Tobias, Meiners, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560391/
https://www.ncbi.nlm.nih.gov/pubmed/26340365
http://dx.doi.org/10.1371/journal.pone.0136188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560391/
https://www.ncbi.nlm.nih.gov/pubmed/26340365
http://dx.doi.org/10.1371/journal.pone.0136188

Ejemplares similares